| SZ CAT No: | CL-PRXB-10 |
| CAS No: | 501093-49-8 |
| Mol.F: | C16H14N2O4S |
| Mol.Wt.: | 330.4 |
| Chemical Name: | N-hydroxy-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide |
| SMILES: | Cc1onc(c2ccccc2)c1c3ccc(cc3)[S](=O)(=O)NO |
| Inventory Status: | Custom synthesis |
This impurity is related to Parecoxib Impurity 7 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Parecoxib Impurity 7 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:N-hydroxy-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Parecoxib Molecular Formula: C16H14N2O4S
Molecular Weight: 330.4
Storage: Store in a cool, dry place.
Cat. No: CL-PRXB-01
CAS No: 198470-84-7
Mol. F: C19H18N2O4S
Mol. Wt: 370.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-02
CAS No: 198470-85-8
Mol. F: C19H18N2O4S : Na
Mol. Wt: 370.4 : 23.0
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-03
CAS No:
Mol. F: C19H18N2O5S
Mol. Wt: 386.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-04
CAS No: 1708094-99-8
Mol. F: C22H23N3O7S2
Mol. Wt: 505.6
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-05
CAS No: 451-40-1
Mol. F: C14H12O
Mol. Wt: 196.3
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-06
CAS No:
Mol. F: C16H14N2O3S
Mol. Wt: 314.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-07
CAS No: 1373038-59-5
Mol. F: C16H15N3O5S2
Mol. Wt: 393.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-08
CAS No: 198471-06-6
Mol. F: C18H16N2O4S
Mol. Wt: 356.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-09
CAS No: 198470-92-7
Mol. F: C20H20N2O4S : Na
Mol. Wt: 384.5 : 23.0
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-11
CAS No: 181696-35-5
Mol. F: C16H13NO4S
Mol. Wt: 315.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-12
CAS No: NA
Mol. F: C17H18N2O4S
Mol. Wt: 346.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-13
CAS No: 181695-72-7
Mol. F: C16H14N2O3S
Mol. Wt: 314.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-14
CAS No: 181696-12-8
Mol. F: C16H14N2O3S
Mol. Wt: 314.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-15
CAS No: 198470-84-7
Mol. F: C19H18N2O4S
Mol. Wt: 370.42
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-16
CAS No: NA
Mol. F: C16H13NO7S2
Mol. Wt: 395.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-17
CAS No: 26306-06-9
Mol. F: C14H13NO
Mol. Wt: 211.3
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-18
CAS No: 1884279-18-8
Mol. F: C18H17NO4S
Mol. Wt: 343.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-19
CAS No: NA
Mol. F: C16H15NO2
Mol. Wt: 253.3
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-20
CAS No: 2338845-31-9
Mol. F: C32H24N2O4S
Mol. Wt: 532.6
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-21
CAS No: 386273-25-2
Mol. F: C16H14N2O3S
Mol. Wt: 314.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-22
CAS No: NA
Mol. F: C19H17N2O4S : Na
Mol. Wt: 369.4 : 23.0
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-23
CAS No: NA
Mol. F: C16H14N2O3S
Mol. Wt: 314.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-24
CAS No: 37928-17-9
Mol. F: C16H13NO
Mol. Wt: 235.3
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-25
CAS No: 1709956-89-7
Mol. F: C19H18N2O4S
Mol. Wt: 370.4
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-26
CAS No: 181696-73-1
Mol. F: C16H15NO2
Mol. Wt: 253.3
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-27
CAS No: 1373038-60-8
Mol. F: C32H25N3O6S2
Mol. Wt: 611.7
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-28
CAS No: 198471-07-7
Mol. F: C18H16N2O4S : Na
Mol. Wt: 356.4 : 23.0
Inv. Status: Custom Synthesis
Cat. No: CL-PRXB-29
CAS No: 2235371-89-6
Mol. F: C19H18N2O4S
Mol. Wt: 370.4
Inv. Status: Custom Synthesis
| CAT No: | CL-PRXB-10 |
| CAS No: | 501093-49-8 |
| Mol.F: | C16H14N2O4S |
| Mol.Wt: | 330.4 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: